Finance

Lists
Q3 2026 earnings • in 4 days
See details
CNS:NYSE
Cohen & Steers, Inc.
$69.26
-2.05%
(-1.45) 1D
Oct 9, 4:00:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNS...
Open
$70.12
High
$71.42
Low
$69.13
Mkt. cap
3.56B
Avg. vol.
292.84K
Volume
0.00
Dividend
3.87%
Quarterly dividend
$0.67
Ex-dividend date
Aug 10, 2026
P/E ratio
21.27
52-wk high
$86.56
52-wk low
$58.39
EPS
$3.26
Beta
1.22
Shares outstanding
51.42M
No. of employees
424
Open
$70.12
High
$71.42
Low
$69.13
Mkt. cap
3.56B
Avg. vol.
292.84K
Volume
0.00
Dividend
3.87%
Quarterly dividend
$0.67
Ex-dividend date
Aug 10, 2026
P/E ratio
21.27
52-wk high
$86.56
52-wk low
$58.39
EPS
$3.26
Beta
1.22
Shares outstanding
51.42M
No. of employees
424
News stories
From web sources and news partners
About Cohen & Steers, Inc.
CEO-
Employees424
Founded1986
HeadquartersNew York, New York, United States
SectorCapital market
Websitecohenandsteers.com
Analyst ratings
Based on 2 analysts giving stock ratings to CNS in the past 3 months
Hold
Buy
1
Hold
0
Sell
1
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for CNS in the last 3 months.
Highest
Current $69.26
$88.00 (+27.06%)
Average
$74.00 (+6.84%)
Lowest
$60.00 (-13.37%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Bank of America Securities
Sell
Reiterated
$60.00
-13.4%
10/05/2026
John Dunn
Evercore ISI
Buy
Maintained
$88.00
+27.1%
08/10/2026
Glenn Schorr
Evercore ISI
Buy
Reiterated
$75.00
+8.3%
04/10/2026
Craig Siegenthaler
Bank of America Securities
Sell
Maintained
$53.00
-23.5%
04/05/2026
Next call in 4 days
Fri, Oct 16, 4:00 PM
Fiscal period
Q3 2026
- / $0.92
Revenue / Est. (USD)
- / 156.77M
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
141.72M
143.80M
145.64M
152.73M
Cost of goods sold
73.52M
81.75M
74.04M
78.40M
Cost of revenue
73.52M
81.75M
74.04M
78.40M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.78M
19.21M
18.90M
18.95M
Operating expense
19.29M
21.75M
21.48M
21.56M
Total operating expenses
92.82M
103.49M
95.52M
99.96M
Operating income
48.90M
40.31M
50.12M
52.78M
Other non operating income
-
-
-
-
EBT including unusual items
55.56M
42.29M
57.20M
72.01M
EBT excluding unusual items
54.87M
44.54M
56.19M
57.83M
Income tax expense
13.92M
11.58M
15.98M
16.45M
Effective tax rate
25.06%
27.40%
27.94%
22.84%
Other operating expenses
-
-
-
-
Net income
41.71M
34.88M
42.37M
49.34M
Net profit margin
29.43%
24.25%
29.09%
32.31%
Earnings per share
0.81
0.81
0.79
0.85
Interest and investment income
5.11M
5.22M
5.31M
5.22M
Interest expense
-
-
-
-
Net interest expenses
5.11M
5.22M
5.31M
5.22M
Depreciation and amortization charges
2.52M
2.54M
2.57M
2.61M
EBITDA
51.90M
41.97M
53.25M
55.90M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps